Molecular Imaging: Page 70

MET-PET detects early patient response to CIRT

By Will Morton

PET/CT imaging with carbon-11 methionine (MET) appears promising for detecting early patient response to neoadjuvant carbon ion radiotherapy (CIRT), according to a study published August 11 in Scientific Reports.

August 16, 2022

Alzheimer's researchers find high PET tracer uptake in women's skulls

By Will Morton

PET radiotracer uptake in women's skulls may cloud imaging results showing signs of early Alzheimer's disease, researchers found in a study published August 11 in the Journal of Nuclear Medicine.

August 15, 2022

Panel tackles woes of enrolling patients in Alzheimer's trials

By Will Morton

People who want to participate in clinical trials for Alzheimer's disease face a number of barriers, according to a panel chaired by U.S. experts. Their solutions for addressing this problem were published August 10 in Alzheimer's & Dementia: the Journal of the Alzheimer's Association.

August 11, 2022

Bolivia opens nuclear medicine research center

By Will Morton

Bolivia has begun pilot operations at a nuclear research center on the outskirts of La Paz -- a location more than 13,000 feet above sea level. The facility is the highest-altitude site in the world producing radioisotopes for use in medicine, according to an August 9 report in World Nuclear News.

August 11, 2022

Total-body PET/CT tested in COVID-19 patients

By AuntMinnie.com staff writers

Researchers at the University of California, Davis recently tested the use of a total-body PET/CT scanner in COVID-19 patients, with results shedding light on the body's immunological response to the disease.

August 10, 2022

PET/MRI shows promise diagnosing bone infection

By Will Morton

While PET/MRI scanners aren't widely available, a group of orthopedic surgeons in the Netherlands say physicians with access should consider the hybrid modality over other imaging techniques for diagnosing patients with suspected chronic osteomyelitis.

August 9, 2022

Can body composition analysis monitor NETs on CT?

By Erik L. Ridley

Body composition analysis of routine PET/CT staging exams could be used to opportunistically monitor patients with neuroendocrine tumors (NETs) of a gastroenteropancreatic origin, according to research published on August 4 in Scientific Reports.

August 8, 2022

PET scans reveal brain activity related to menopause

By Will Morton

PET scans have demonstrated for the first time that only women appear to experience specific cellular neuroinflammation related to aging in the brain's hypothalamus, a process that may be related to menopause, according to a study published on August 3 in Scientific Reports.

August 8, 2022

Lantheus posts healthy 2022 Q2 revenues

By AuntMinnie.com staff writers

Lantheus Medical Imaging parent company Lantheus Holdings reported a 121.4% increase in revenue in its 2022 second quarter, as well as net income compared to a net loss in 2021.

August 7, 2022

Week in Review: AI creates x-ray images from US | PET for Alzheimer's | AI webinar on Aug. 10

By Brian Casey

August 5, 2022

Radiopharm collaborates with Lantheus on theranostic agent

By AuntMinnie.com staff writers

Radiopharm Theranostics has entered a collaboration agreement with Lantheus to develop NM-01, a nanobody that can be labeled with radioisotopes to diagnose and treat tumors for theranostic applications.

August 3, 2022

ACR to manage network for Alzheimer's research

By AuntMinnie.com staff writers

The American College of Radiology's (ACR) Center for Research and Innovation will manage the new Alzheimer's Network for Treatment and Diagnostics, which will collect data on patients being treated for Alzheimer's disease.

August 3, 2022

Previous Page

Page 70 of 620

Next Page